Know Cancer

or
forgot password

WT-1's Role in Leukemogenesis


N/A
N/A
N/A
Open (Enrolling)
Both
Leukemia

Thank you

Trial Information

WT-1's Role in Leukemogenesis


OBJECTIVES:

- To measure WT1 and VEGF-1 expression in patients with acute promyelocytic leukemia.

OUTLINE: This is a multicenter study.

Patient mRNA samples from diagnosis are analyzed via quantitative PCR to measure WT1 and
VEGF-1 expression.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of acute promyelocytic leukemia [t(15;17) translocation]

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

WT1 and VEGF-1 expression

Safety Issue:

No

Principal Investigator

Mustafa M. Moazam, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Akron Children's Hospital

Authority:

United States: Federal Government

Study ID:

CDR0000671471

NCT ID:

NCT01146223

Start Date:

September 2009

Completion Date:

Related Keywords:

  • Leukemia
  • adult acute promyelocytic leukemia (M3)
  • childhood acute promyelocytic leukemia (M3)
  • adult acute myeloid leukemia with t(15;17)(q22;q12)
  • adult acute myeloid leukemia
  • Leukemia
  • Leukemia, Promyelocytic, Acute

Name

Location